Product
NaCl 0.9%
Aliases
NaCl 0.9% 100ml
6 clinical trials
17 indications
Indication
Brain DiseasesIndication
strokeIndication
IschemiaIndication
StrokeIndication
AtherosclerosisIndication
IntracranialIndication
Myocardial InfarctionIndication
Ischemia-reperfusion injuryIndication
Reperfusion InjuryIndication
MyocardialIndication
Reperfusion ArrhythmiasIndication
chronic kidney diseaseIndication
Cardiac DiseaseIndication
IL-6Indication
Endovascular TreatmentIndication
AnxietyIndication
Acute Kidney InjuryClinical trial
Effect of Interleukin-6 Receptor Inhibition for Avoiding Recurrence of Ischemic Stroke in Patients With Symptomatic Intracranial Atherosclerosis: a Double-blind, Randomized, Placebo-controlled TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
Cardioprotection of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Angioplasty Through a Combined Antioxidant Therapy. A Phase I, Randomized Clinical Trial.Status: Completed, Estimated PCD: 2022-11-22
Clinical trial
Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney DysfunctionStatus: Completed, Estimated PCD: 2021-12-31
Clinical trial
Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment: a Double-blind, Randomized, Placebo-controlled TrialStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Resistance Under the Microscope; a Randomized Placebo Controlled Parallel Group DesignStatus: Completed, Estimated PCD: 2011-09-01
Clinical trial
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation: a Multi-center, Randomized, Double-blind, Placebo-controlled Investigational Study (PAIR-TAVI).Status: Recruiting, Estimated PCD: 2025-03-01